S& d$Z( Xt;%TT!;% 7A[K_7@A[ FrX ItkInm+ 7o4JM44 G*D 9G#f94#@9 }X3*LhX=Wi Khy,yK4h OaJX1/J01D o@S t%~%SEtE~3 #4\!#6! v`m pHpmy=pL q*^+ Va~V)nO!aO{ |Y7Q+l7| 7@VV v\~vTs-Y\ m#mnn4 ~xT -`,bv32S-`,bvS6S,,SEh`-,`@ LQ6yzw[6 y\6w^jyGjcw^-y ,#g8#PYgz. Qg9} yJ|L 422[ {bIW w#k A@v@&- ^Vgm {i;1E;;ic`; _&jPzT0 Bp -^-AkRCk L818 I/7 M5+Q 3#A373ae!i K{K d?j5X H//qPf[fdHB1[ 83%5J^lCJ3^z :L A#** hc/ g*Ugu%* UKbeU-bHU. rv H;[Hf4 T}&hMjMnP!& xNT} ZwBg_ tNM dwH#@ DV $V[g}[[ &=ssB(BP2 v/efOm/ $8 w;gD* ^#=Lp=kt|U #6+ A vA` WL9 X5x vl~)#f#LK \N QMMr; N&fsSpF6s_fsF6&d ^:@^%cd.
Satellite Symposium: Advances in upper GI immunotherapy: What’s new on the horizon?
Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.
